This NOFO invites applications for a Biostatistics Research Center to participate in a consortium aimed at improving understanding of heterogeneity of type 2 diabetes (T2D). A separate NOFO (RFA-DK-23-019) will bring together investigative teams for integration of multiple data types, including markers of organ or tissue function, into analysis approaches for stratifying individuals T2D and developing more precise definitions of disease. The ultimate goal of this effort will be to 1) develop a broadly applicable framework for identifying subtypes of T2D; and 2) increase understanding of the physiologic drivers of T2D subtypes to guide development of more effective precision interventions.
Deadlines:
Letter of Intent Due Date(s): September 26. 2023
Application Due Date: October 26, 2023
RFA-DK-23-020 Expiration Date October 27, 2023
Application budgets should reflect the actual needs of the proposed project and should not exceed $1,000,000 per year in direct costs.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
